Hyperthyroidism is common in older cats, but the treatment decision can feel bigger than a single blood result. Owners often need to weigh I-131, medication, diet, kidney disease, blood pressure, isolation, cost and follow-up.
The guidance and studies below are useful because they turn the decision into practical questions: is the diagnosis secure, what else is happening in the cat's body, is I-131 suitable now, and what needs to be monitored after treatment?
The 2023 AAHA endocrine guidance and the 2016 AAFP feline hyperthyroidism guidelines both frame untreated hyperthyroidism as a progressive disease that affects more than weight and appetite. Thyroid hormone affects the heart, kidneys, blood pressure, metabolism, behaviour and muscle condition.
For owners, that means treatment should not be delayed just because a cat still eats well or seems energetic. The useful question is how to treat safely while also watching the kidney, heart and blood-pressure picture that may become clearer as thyroid hormone is controlled.
AAHA describes radioactive iodine as the treatment of choice for many stable hyperthyroid cats, with cure reported in more than 95% of cases in the guideline summary. It avoids daily medication, general anaesthesia and restrictive feeding, and it targets the abnormal thyroid tissue.
That does not mean I-131 is a no-monitoring treatment. Recent radioiodine studies show that outcome varies between cats, and some cats can be persistently hyperthyroid or become overtly or subclinically hypothyroid. Follow-up thyroid and kidney testing is therefore part of good care, not an optional extra.
Both guideline and research literature are clear that hyperthyroidism can make kidney function difficult to interpret. When thyroid hormone is lowered, kidney disease that was partly hidden may become more visible. This is why kidney values, urine concentration, blood pressure and clinical signs matter before and after treatment.
Recent work on urine concentrating ability after radioiodine suggests that cats with lower urine concentrating ability before treatment are more likely to develop azotaemia afterwards. That supports a practical approach: assess kidney context early, warn owners honestly, and keep monitoring after thyroid control is achieved.
Use this when the key question is what testing should be done before or after treatment.
Use this when the family is comparing I-131, medication, diet and other choices.
Use this when I-131 is likely and the practical treatment process needs to be understood.
Use this when the diagnosis is new and the disease itself still needs explanation.
AAHA highlights that hyperthyroidism is very common in older cats, that signs can be subtle, and that senior cats with high-normal T4 values may still need context if the value is rising over time. This supports looking at the trend, the cat's body condition, appetite, behaviour and other health changes rather than treating one laboratory number in isolation.
Reference: AAHA feline hyperthyroidism guidance.
The diagnostic guidance is useful because it explains why some cats are not classic. A repeatedly high T4 requires treatment, while borderline or complicated cases may need free T4, TSH, urine testing, blood pressure and wider senior-cat assessment. TSH can also help identify cats at higher risk of I-131-associated hypothyroidism.
Reference: AAHA diagnostic testing and monitoring guidance.
AAHA describes I-131 as the treatment of choice for many stable cats because it avoids anaesthesia, daily medication and restrictive feeding, while aiming to cure the disease. The same guidance also explains why medication, diet or surgery may still have a role depending on stability, concurrent disease, availability and family circumstances.
Reference: AAHA feline hyperthyroidism therapy guidance.
The AAFP guidelines remain useful because they connect diagnosis with the whole older-cat picture: blood pressure, kidney staging, urine protein, body condition, muscle condition and heart signs. They also caution against leaving cats mildly hyperthyroid to make kidney values look better, because that can worsen kidney and cardiovascular stress.
Reference: AAFP feline hyperthyroidism guidelines.
Recent studies of I-131 dosing and outcomes show why follow-up is still needed after a highly effective treatment. Many cats become euthyroid, but a smaller number remain hyperthyroid or become overtly or subclinically hypothyroid. Pretreatment TSH, age, disease pattern and kidney context can all matter in the follow-up conversation.
Reference: 2022 radioiodine outcome study.
The New Zealand radiation code matters because I-131 is not just a medication; it is a radioactive material that requires licensing, shielding, safe handling, waste management and trained procedures. This is why the admission, isolation and discharge instructions are part of the treatment, not an administrative formality.
Reference: New Zealand Code of Practice for Veterinary Radiation.
If you are weighing I-131, medication, kidney concerns or follow-up testing for your cat, we can help translate the evidence into a practical plan for the cat in front of us.
Return to the main Takurua Vets I-131 page for the service overview.
Blood and urine testing help us monitor thyroid control, kidney changes and wider senior-cat health.
Hyperthyroidism decisions often sit alongside ageing, chronic disease, comfort and family capacity.
